ATAD2-IN-1, identified by its CAS number 3004556-06-0, is a small molecule inhibitor that targets the ATAD2 protein, which is implicated in various cellular processes, including gene regulation and chromatin remodeling. This compound is characterized by its ability to selectively inhibit the activity of ATAD2, making it a potential candidate for therapeutic applications, particularly in cancer treatment where ATAD2 is often overexpressed. The chemical structure of ATAD2-IN-1 typically features specific functional groups that enhance its binding affinity to the target protein. Its efficacy and specificity are subjects of ongoing research, with studies focusing on its pharmacokinetics, bioavailability, and potential side effects. As a research tool, ATAD2-IN-1 contributes to the understanding of ATAD2's role in cellular mechanisms and may pave the way for the development of novel therapeutic strategies targeting ATAD2-related pathways.

ATAD2-IN-1

3004556-06-0: ATAD2-IN-1, identified by its CAS number 3004556-06-0, is a small molecule inhibitor that targets the ATAD2 protein, which is implicated in various cellular processes, including gene regulation and chromatin remodeling. This compound is characterized by its ability to selectively inhibit the activity of ATAD2, making it a potential candidate for therapeutic applications, particularly in cancer treatment where ATAD2 is often overexpressed. The chemical structure of ATAD2-IN-1 typically features specific functional groups that enhance its binding affinity to the target protein. Its efficacy and specificity are subjects of ongoing research, with studies focusing on its pharmacokinetics, bioavailability, and potential side effects. As a research tool, ATAD2-IN-1 contributes to the understanding of ATAD2's role in cellular mechanisms and may pave the way for the development of novel therapeutic strategies targeting ATAD2-related pathways.

<p>ATAD2-IN-1 (compound 19f) serves as a potent ATAD2 inhibitor (IC 50: 0.27 μM), capable of inducing apoptosis. Additionally, it suppresses c-Myc activation and impedes the migration of BT-549 cells [1].</p>

CAS 3004556-06-0

ATAD2-IN-1

ATAD2-IN-1

Ref: TM-T85738